Dr Fabienne Brilot-Turville’s research  

At least 5% of all people with multiple sclerosis experience the clinical onset of their disease prior to 18 years.  

Dr Fabienne Brilot-Turville’s research at The Children’s Hospital Westmead and University of Sydney will identify the earliest immune responses against the brain in children who develop MS.  Identifying these early immune responses will allow early and directed treatments to prevent disability and death in the future.  

The triggering events that cause MS in all sufferers are determined in childhood.  Paediatric patients are important as they offer the opportunity to investigate the earliest possible inflammatory reaction against the brain before progression to MS and therefore, to understand MS causation.